FTC Sues Big Three PBMs for Artificially Inflating Insulin Prices Through Rebate Schemes
The Federal Trade Commission filed an administrative antitrust complaint against the three largest pharmacy benefit managers—CVS Caremark, Express Scripts (Cigna), and OptumRx (UnitedHealth)—and their affiliated group purchasing organizations, charging them with anticompetitive and unfair practices …
Federal Trade Commission
Lina Khan
CVS Caremark
Express Scripts
OptumRx
+3 more
healthcare
pbm
pharmacy
antitrust
ftc
+3 more
Read more →